References
- Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. "The reports of my demise have been greatly exaggerated." (after a quotation from Mark Twain). Acta Cytol. 2015;59(2):121–132. doi:https://doi.org/10.1159/000381842.
- Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, 2012 ASCCP Consensus Guidelines Conference, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829–846. doi:https://doi.org/10.1097/AOG.0b013e3182883a34.
- DeSimone CP, Day ME, Tovar MM, Dietrich CS, III, Eastham ML, Modesitt SC. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol. 2006;107(6):1285–1291.
- Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic women’s hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114(3):383–389. doi:https://doi.org/10.1016/j.ygyno.2009.05.019.
- Gustapane S, Leombroni M, Khalil A, Giacci F, Marrone L, Bascietto F, et al. Systematic review and meta-analysis of persistent left superior vena cava on prenatal ultrasound: associated anomalies, diagnostic accuracy and postnatal outcome. Ultrasound Obstet Gynecol. 2016;48(6):701–708. doi:https://doi.org/10.1002/uog.15914.
- Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol. 1998;91(2):278–282. doi:https://doi.org/10.1016/S0029-7844(97)00659-5.
- Nasu I, Meurer W, Fu YS. Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology. Int J Gynecol Pathol. 1993;12(3):208–218. doi:https://doi.org/10.1097/00004347-199307000-00002.
- Raab SS, Geisinger KR, Silverman JF, Thomas PA, Stanley MW. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance. Am J Clin Pathol. 1998;110(5):653–659. doi:https://doi.org/10.1093/ajcp/110.5.653.
- Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, Zambeli ER, Westin MC, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol. 2004;95(3):618–623. doi:https://doi.org/10.1016/j.ygyno.2004.08.033.
- Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol. 2004;121(1):87–92. doi:https://doi.org/10.1309/N7KCUP0VD59GDJEL.
- Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. Obstet Gynecol. 2010;115(2 Pt 1):243–248. doi:https://doi.org/10.1097/AOG.0b013e3181c799a3.
- Wang SS, Sherman ME, Hildesheim A, Lacey JV, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer. 2004;100(5):1035–1044. doi:https://doi.org/10.1002/cncr.20064.
- Patadji S, Li Z, Pradhan D, Zhao C. Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: analysis of 1857 cases from an academic institution. Cancer Cytopathol. 2017;125(3):205–211. doi:https://doi.org/10.1002/cncy.21791.
- Chen L, Yang B. Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytology. Cancer. 2008;114(4):236–241. doi:https://doi.org/10.1002/cncr.23639.
- Kim MK, Lee YK, Hong SR, Lim KT. Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears. Diagn Cytopathol. 2017;45(10):867–872. doi:https://doi.org/10.1002/dc.23777.
- Schnatz PF, Sharpless KE, O'Sullivan DM. Use of human papillomavirus testing in the management of atypical glandular cells. J Low Genit Tract Dis. 2009;13(2):94–101. doi:https://doi.org/10.1097/LGT.0b013e318183a438.
- Zhao C, Austin M, Pan J, Barr N, Martin SE, Raza A, Cobb C. Clinical significance of atypical glandular cells in conventional pap smears in a large, high-risk U.S. west coast minority population. Acta Cytol. 2009;53(2):153–159. doi:https://doi.org/10.1159/000325117.
- Guan P, Clifford GM, Franceschi S. Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies. Int J Cancer. 2013;132(1):248–250. doi:https://doi.org/10.1002/ijc.27663.
- So KA, Kim MJ, Lee KH, Lee IH, Kim MK, Lee YK, et al. The impact of high-risk HPV genotypes other than HPV 16/18 on the natural course of abnormal cervical cytology: a Korean HPV cohort study. Cancer Res Treat. 2016;48(4):1313–1320. doi:https://doi.org/10.4143/crt.2016.013.
- Sharpless KE, O'Sullivan DM, Schnatz PF. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. J Low Genit Tract Dis. 2009;13(2):72–78. doi:https://doi.org/10.1097/LGT.0b013e318183bb0e.
- Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36(10):3020–3027. doi:https://doi.org/10.1128/JCM.36.10.3020-3027.1998.
- Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357–61. doi:https://doi.org/10.1128/JCM.38.1.357-361.2000.
- Saqi A, Gupta PK, Erroll M, Babiac A, Blackmun D, Mansukhani M, Vazquez M. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells. Diagn Cytopathol. 2006;34(3):235–239. doi:https://doi.org/10.1002/dc.20369.